Submission Details
| 510(k) Number | K200276 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2020 |
| Decision Date | February 06, 2021 |
| Days to Decision | 368 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K200276 is an FDA 510(k) clearance for the SPEAC System, a Physiological Signal Based Seizure Monitoring System (Class II — Special Controls, product code POS), submitted by Brain Sentinel, Inc. (San Antonio, US). The FDA issued a Cleared decision on February 6, 2021, 368 days after receiving the submission on February 4, 2020. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1580.
| 510(k) Number | K200276 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2020 |
| Decision Date | February 06, 2021 |
| Days to Decision | 368 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | POS — Physiological Signal Based Seizure Monitoring System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1580 |
| Definition | The Physiological Signal Based Seizure Monitoring System Is A Prescription Device That Uses Physiological Signal To Identify Abnormal Physiological Activity That May Be Associated With A Seizure. The System Does Not Predict Seizure Onsets, And Is Not Intended As A Standalone Seizure Monitoring Device. |